Publications

Human B cell Responses to Dominant and Sub-dominant Antigens induced by a Meningococcal Outer Membrane Vesicle Vaccine in a Phase I trial

Journal article

MAIDEN M. et al, (2022), mSphere

Indirect effects of the covid-19 pandemic on childhood infection in England: population based observational study.

Journal article

Kadambari S. et al, (2022), BMJ, 376

A Randomized, Phase 3, Trial of Interferon-α versus Hydroxyurea in Polycythemia Vera and Essential Thrombocythemia.

Journal article

Mascarenhas J. et al, (2022), Blood

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Journal article

Abani O. et al, (2022), The Lancet, 399, 143 - 151

Enhancing the Therapeutic Potential of Extracellular Vesicles Using Peptide Technology

Chapter

Martin Perez C. et al, (2022), Methods in Molecular Biology, 2383, 119 - 141

International links between Streptococcus pneumoniae vaccine serotype 4 sequence type (ST) 801 in Northern European shipyard outbreaks of invasive pneumococcal disease

Journal article

Gladstone RA. et al, (2022), Vaccine

Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection

Journal article

Feng S. et al, (2021), Nature Medicine

Premature Infants Display Discriminable Behavioral, Physiological, and Brain Responses to Noxious and Nonnoxious Stimuli.

Journal article

van der Vaart M. et al, (2021), Cereb Cortex

Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses.

Dejnirattisai W. et al, (2021)

Childhood Invasive Bacterial Disease in Kathmandu, Nepal (2005-2013).

Journal article

Carter MJ. et al, (2021), Pediatr Infect Dis J

The half-life of maternal transplacental antibodies against diphtheria, tetanus, and pertussis in infants: an individual participant data meta-analysis.

Journal article

Oguti B. et al, (2021), Vaccine

Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum.

Journal article

Dejnirattisai W. et al, (2021), Lancet

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.

Journal article

Ramasamy MN. et al, (2021), Lancet, 396, 1979 - 1993

Author Correction: GAPDH controls extracellular vesicle biogenesis and enhances the therapeutic potential of EV mediated siRNA delivery to the brain.

Journal article

Dar GH. et al, (2021), Nat Commun, 12

The impact of premature extrauterine exposure on infants' stimulus-evoked brain activity across multiple sensory systems.

Journal article

Schmidt Mellado G. et al, (2021), Neuroimage Clin, 33

Understanding the interaction between cytomegalovirus and tuberculosis in children: The way forward

Journal article

Olbrich L. et al, (2021), PLOS Pathogens, 17, e1010061 - e1010061

Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial.

Journal article

Stuart ASV. et al, (2021), Lancet

Why do breakthrough COVID-19 infections occur in the vaccinated?

Journal article

Maclean P. et al, (2021), QJM

FOXN1 forms higher-order nuclear condensates displaced by mutations causing immunodeficiency.

Journal article

Rota IA. et al, (2021), Sci Adv, 7

Preclinical characterization of antagomiR-218 as a potential treatment for myotonic dystrophy.

Journal article

Cerro-Herreros E. et al, (2021), Mol Ther Nucleic Acids, 26, 174 - 191